Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia
NCT ID: NCT00117546
Last Updated: 2010-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
35 participants
INTERVENTIONAL
2005-09-30
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape)
NCT01361425
Effect of Methyldopa on Uterine Artery Diameter in Pregnant Women With Mild Preeclampsia
NCT01674127
Preeclampsia Intervention Netherlands
NCT06452498
Study of Nicotinamide in Early Onset Preeclampsia
NCT03419364
Early Vascular Adjustments to Prevent Preeclampsia
NCT04216706
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
alpha methyldopa
500 mg twice a day
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of preeclampsia
* Low plasma volume
Exclusion Criteria
* Hypertension
* Auto-immune disorder
* Insulin dependent diabetes mellitus
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Radboud University Medical Center
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ineke Krabbendam, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Radboud University Nijmegen Medical Center
Nijmegen, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P05.0007L
Identifier Type: -
Identifier Source: secondary_id
2004-155
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.